Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abano Healthcare Group Ltd Issues 2013 EBITDA Guidance; Issues 2013 Revenue, NPAT Guidance Below Analysts' Estimates


Monday, 25 Mar 2013 09:22pm EDT 

Abano Healthcare Group Ltd announced that for fiscal 2013, following the divestment of Abano Rehabilitation in June 2012, the Company expects reported consolidated revenues to grow to between $207.0 million to $209.0 million, with an Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) of between $27.5 million to $28.5 million and a Net Profit After Tax (NPAT) of between $2.3 million to $2.8 million. Underlying EBITDA is expected to be between $28.3 million to $29.3 million, resulting in an underlying NPAT of between $4.1 million to $4.6 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenues of $215.1 million, Net Income $3.57 million for fiscal 2013. 

Company Quote

7.4
-0.04 -0.54%
19 Dec 2014